Back

Clinical application of virtual antiarrhythmic drug test using digital twins in patients who recurred atrial fibrillation after catheter ablation

16 April 2023 (09:40 - 10:40)
Organised by:
Congress Presentation Part of: Atrial Fibrillation - Round 9 - Ablation - Outcomes Rhythm Control, Antiarrhythmic Drugs EHRA Premium Access EHRA 2023

About the speaker

Photo
Doctor Taehyun Hwang

Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul (Korea (Republic of))

9 More presentations in this session

Presentation thumbnail
Local conduction velocities determined by non-invasive electrocardiographic imaging predict arrhythmia-free survival after pulmonary vein isolation
Mr E. Invers-Rubio (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Diagnostic accuracy of smart gadgets/wearable devices in detecting atrial fibrillation in primary prevention: a meta-analysis
Doctor G. Vetta (Brussels, BE)
Abstract Slides
Presentation thumbnail
Quality of life and perception after pulmonary vein isolation and app-based mental training - Results from the randomized controlled MENTAL AF Trial
Doctor J. Lurz (Mainz, DE)
Abstract Slides
Presentation thumbnail
Anterior mitral line in patients with persistent AF and anterior scar: a multicenter matched comparison. The MiLine Study
Doctor M. Bergonti (Lugano, CH)
Abstract Slides
Presentation thumbnail
A novel saline-based occlusion tool allows for dye-less cryoballoon-based pulmonary vein isolation and fluoroscopy reduction
Doctor L. Rottner (Frankfurt, DE)
Abstract Slides

Access the full session

Session thumbnail
Atrial Fibrillation - Round 9 - Ablation - Outcomes

The Event

Event poster

EHRA 2023

16 April 2023 09:40 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources